{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-29",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Berwyn",
      "state": "PA",
      "country": "United States",
      "classification": "Class III",
      "openfda": {
        "application_number": [
          "NDA022430"
        ],
        "brand_name": [
          "TRANEXAMIC ACID"
        ],
        "generic_name": [
          "TRANEXAMIC ACID"
        ],
        "manufacturer_name": [
          "Nordic Pharma, Inc."
        ],
        "product_ndc": [
          "69918-301"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "ORAL"
        ],
        "substance_name": [
          "TRANEXAMIC ACID"
        ],
        "rxcui": [
          "883826"
        ],
        "spl_id": [
          "7bafece1-f0b8-4852-92ca-fe2bf261be04"
        ],
        "spl_set_id": [
          "031bf7c2-3b07-469d-bc5a-31fc6238e25f"
        ],
        "package_ndc": [
          "69918-301-30"
        ],
        "is_original_packager": [
          true
        ],
        "nui": [
          "N0000175634",
          "N0000175632"
        ],
        "pharm_class_epc": [
          "Antifibrinolytic Agent [EPC]"
        ],
        "pharm_class_pe": [
          "Decreased Fibrinolysis [PE]"
        ],
        "unii": [
          "6T84R30KC1"
        ]
      },
      "product_type": "Drugs",
      "event_id": "92458",
      "recalling_firm": "Amring Pharmaceuticals Inc",
      "address_1": "1205 Westlakes Dr Ste 275",
      "address_2": "N/A",
      "postal_code": "19312-2411",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide in the USA.",
      "recall_number": "D-0871-2023",
      "product_description": "Lysteda (tranexamic acid) USP Tablets, 650 mg, 30 tablets per bottle, Rx Only, Manufactured for: Amring Pharmaceuticals Inc. Berwyn, PA 19312, NDC 69918-301-30",
      "product_quantity": "48,989 bottles",
      "reason_for_recall": "Failed Impurities/Degradation Specifications: Out of specification results obtained for conductivity.",
      "recall_initiation_date": "20230612",
      "center_classification_date": "20230614",
      "termination_date": "20240529",
      "report_date": "20230621",
      "code_info": "Lots: X220317A and X220318A, exp. date 09/25"
    }
  ]
}